Status:
UNKNOWN
Growth and Body Composition in Preterm Infants
Lead Sponsor:
Oswaldo Cruz Foundation
Conditions:
Body Composition
Eligibility:
All Genders
Up to 6 years
Brief Summary
Growth is traditionally used as a prognostic measure after admission to a neonatal intensive care unit (NICU). Quality of neonatal intensive care is one of the factors determining the health and quali...
Detailed Description
OBJECTIVES GENERAL: Evaluate the growth and body composition of VLBW infants upon reaching the corresponding term gestational age (GA) and weight. SPECIFIC: A) Evaluate the longitudinal growth and...
Eligibility Criteria
Inclusion
- appropriate for gestational age (AGA) and small for gestational age (SGA) premature newborns with gestational age less than or equal to 32 weeks and less than 1500g at birth
- AGA term newborns with gestational age greater than or equal to 37 weeks and less than 42 weeks and with no history of maternal disease that might compromise intrauterine growth
Exclusion
- congenital malformations
- genetic syndromes confirmed by the geneticist
- clinically and laboratory-confirmed congenital infections
- children of mothers with the human immunodeficiency virus (HIV)
- children of diabetic mothers
- newborns that develop severe intraventricular hemorrhage or necrotizing enterocolitis
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00875251
Start Date
April 1 2009
End Date
December 30 2021
Last Update
September 18 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Fernandes Figueira
Rio de Janeiro, Rio de Janeiro, Brazil, 22520-040
2
Maria Elisabeth L Moreira
Rio de Janeiro, Brazil, 22420040